Search

Your search keyword '"Mebazaa A"' showing total 372 results

Search Constraints

Start Over You searched for: Author "Mebazaa A" Remove constraint Author: "Mebazaa A" Topic female Remove constraint Topic: female
372 results on '"Mebazaa A"'

Search Results

1. Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission

2. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study

3. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients

4. Accuracy of a multiparametric score based on pulse wave analysis for prediction of fluid responsiveness: ancillary analysis of an observational study

5. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.

6. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.

7. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

8. Undetectable haptoglobin is associated with major adverse kidney events in critically ill burn patients.

9. Infectious Complications and Immune/Inflammatory Response in Cardiogenic Shock Patients

10. Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction

11. Evidence of Uncoupling between Renal Dysfunction and Injury in Cardiorenal Syndrome: Insights from the BIONICS Study

12. Gender and survival of critically ill patients: results from the FROG-ICU study

13. The elusive task of biomarkers of renal injury.

14. The Effectiveness of Inodilators in Reducing Short Term Mortality among Patient with Severe Cardiogenic Shock: A Propensity-Based Analysis

15. Cardiac troponin and skeletal muscle oxygenation in severe post-partum haemorrhage

17. The association of biological sex and long-term outcomes in patients with acute dyspnea at the emergency department

18. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

19. Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis*

20. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study

21. Unusual arterial thrombotic events in Covid-19 patients

22. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

23. Response to beta-blockers and natriuretic peptide level in acute heart failure: analysis of data from the Korean acute heart failure registry

24. Accuracy of a multiparametric score based on pulse wave analysis for prediction of fluid responsiveness: ancillary analysis of an observational study

25. Early hypoalbuminemia is associated with 28-day mortality in severely burned patients: A retrospective cohort study

26. Impact of hypotension on cerebral perfusion during general anesthesia induction: A prospective observational study in adults

27. Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction

28. Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission

29. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR) : baseline characteristics

30. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

31. Impact of coronavirus disease 2019 (COVID-19) outbreak on acute admissions at the emergency and cardiology departments across Europe

32. One-Year Prognosis of Kidney Injury at Discharge From the ICU

33. Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial

34. Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approach

35. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

36. Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study

37. Ethnic differences in acute heart failure outcomes in Ontario

38. Characteristics and outcomes of HFpEF with declining ejection fraction

39. Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort study

40. Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry

41. Effectiveness of anaesthesia ventilator use for mechanical ventilation in critically ill patients during the COVID-19 pandemic

42. Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure

43. Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19

44. Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation

45. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

46. Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome

47. PenKid measurement at admission is associated with outcome in severely ill burn patients

48. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications

49. Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes

50. Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients

Catalog

Books, media, physical & digital resources